New attack on rare nerve disease aims to cut harmful steroids
NCT ID NCT07159893
Summary
This study is testing a drug called inectolizumab for people newly diagnosed with a rare autoimmune disease that attacks the nerves and spinal cord (NMOSD). The main goal is to see if the drug can help control the disease while allowing patients to take fewer steroids, which have serious side effects. Researchers will also check if starting this treatment quickly after a disease attack helps improve patients' disability levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.